Francesco Vassalli
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Francesco Vassalli has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Bruno Antonio Zanfini
UOSD Anestesia in Ostetricia, Ginecologia e Terapia del Dolore 2, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy
5 shared publications - Gaetano Draisci
UOSD Anestesia in Ostetricia, Ginecologia e Terapia del Dolore 2, IRCCS Fondazione Policlinico Universitario Agostino Gemelli, 00168 Rome, Italy
5 shared publications - Luciano Frassanito
Department of Anesthesia, Emergency and Intensive care medicine, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy -
5 shared publications - Stefano Catarci
Department of Anesthesiology and Intensive Care Medicine, Catholic University School of Medicine, Rome, Italy
5 shared publications - Nicoletta Filetici
Department of Science of Emergency, Anesthesiology and Intensive Care, IRCCS Policlinico A. Gemelli Foundation, 00168 Rome, Italy
3 shared publications - Alessandra Piersanti
Department of Anesthesia and Intensive Care, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00136 Rome, Italy
2 shared publications
Latest Publications
- Open Access
- 30 April 2026
- Published by MDPI AG in Preprints.org
Continuous Non-Invasive Maternal Hemodynamic Monitoring During Cesarean Delivery Under Spinal Anesthesia: A Retrospective, Observational Study
Background/Objectives: Spinal anesthesia (SA) for elective cesarean delivery (CD) is frequently complicated by maternal hypotension, predominantly attributed to arterial vasodilation and venous pooling. The precise hemodynamic derangements are complex and poorly characterized. We aimed to describe continuous, non-invasively measured maternal hemodynamics changes during CD under SA, focusing on myocardial cardiac contractility (dP/dtmax) and stroke volume index (SVI), and their association with hypotensive episodes. Methods: 95 healthy pregnant women were included. Continuous non-invasive hemodynamic monitoring was performed using a finger-cuff system. We analyzed the incidence, duration, and time-weighted averages (TWA) area under the threshold of hypotension (Mean Arterial Pressure - MAP - <65 mmHg for ≥1 minute), reduced cardiac contractility (dP/dtmax <400 mmHg/sec), and low flow states (SVI <35 mL/b/m2). Results: The median TWA-MAP < 65 mmHg was 0.55 (0.21, 1.13) mmHg, with 2 (1, 5) hypotensive events per patient. Median duration of hypotensive events per patient was 4 (2, 17) min, corresponding to a 5 (2, 15) % of the total monitoring time. Sixty patients (63%) showed a reduced cardiac contractility that averaged 346 (326, 366) mmHg/sec. In 30 patients (31%) at least 1 episode of hypotension (MAP 1 minute) was associated with reduced cardiac contractility and a low flow state. In 11 parturients (11%) hypotension was associated to reduced myocardial contractility, while in 8 patients (8%) to low flow alone. Only 9 patients (9%) maintained normal values across all three hemodynamic parameters assessed. No significant correlation emerged between age, body mass index, TWA-MAP, TWA-SVI and TWA-dP/dtmax. Conclusions: Reduced cardiac contractility and low flow states during CD under SA are frequent, but individual expression and the consequent blood pressure decline vary widely. Continuous non-invasive monitoring provides critical, real-time physiological insights that could facilitate individualized, hemodynamically targeted therapies in obstetric anesthesia.
- 30 April 2026
- Published by MDPI AG in Preprints.org
Open AccessContinuous Non-Invasive Maternal Hemodynamic Monitoring During Cesarean Delivery Under Spinal Anesthesia: A Retrospective, Observational Study
Background/Objectives: Spinal anesthesia (SA) for elective cesarean delivery (CD) is frequently complicated by maternal hypotension, predominantly attributed to arterial vasodilation and venous pooling. The precise hemodynamic derangements are complex and poorly characterized. We aimed to describe continuous, non-invasively measured maternal hemodynamics changes during CD under SA, focusing on myocardial cardiac contractility (dP/dtmax) and stroke volume index (SVI), and their association with hypotensive episodes. Methods: 95 healthy pregnant women were included. Continuous non-invasive hemodynamic monitoring was performed using a finger-cuff system. We analyzed the incidence, duration, and time-weighted averages (TWA) area under the threshold of hypotension (Mean Arterial Pressure - MAP - <65 mmHg for ≥1 minute), reduced cardiac contractility (dP/dtmax <400 mmHg/sec), and low flow states (SVI <35 mL/b/m2). Results: The median TWA-MAP < 65 mmHg was 0.55 (0.21, 1.13) mmHg, with 2 (1, 5) hypotensive events per patient. Median duration of hypotensive events per patient was 4 (2, 17) min, corresponding to a 5 (2, 15) % of the total monitoring time. Sixty patients (63%) showed a reduced cardiac contractility that averaged 346 (326, 366) mmHg/sec. In 30 patients (31%) at least 1 episode of hypotension (MAP 1 minute) was associated with reduced cardiac contractility and a low flow state. In 11 parturients (11%) hypotension was associated to reduced myocardial contractility, while in 8 patients (8%) to low flow alone. Only 9 patients (9%) maintained normal values across all three hemodynamic parameters assessed. No significant correlation emerged between age, body mass index, TWA-MAP, TWA-SVI and TWA-dP/dtmax. Conclusions: Reduced cardiac contractility and low flow states during CD under SA are frequent, but individual expression and the consequent blood pressure decline vary widely. Continuous non-invasive monitoring provides critical, real-time physiological insights that could facilitate individualized, hemodynamically targeted therapies in obstetric anesthesia.
- Open Access
- 30 December 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (1) , 58
Personalized Predictive Hemodynamic Management for Gynecologic Oncologic Surgery: Feasibility of Cost–Benefit Derivatives of Digital Medical Devices
Background: Intraoperative hypotension is associated with increased perioperative complications, hospital length of stay (LOS) and healthcare expenditure in gynecologic surgery. We tested the hypothesis that the adoption of a machine learning-based warning algorithm (hypotension prediction index—HPI) might yield an economic advantage, with a reduction in adverse outcomes that outweighs the costs for its implementation as a medical device. Methods: A retrospective-matched cohort cost–benefit Italian study in gynecologic surgery was conducted. Sixty-six female patients treated with standard goal-directed therapy (GDT) were matched in a 2:1 ratio with thirty-three patients treated with HPI based on ASA status, diagnosis, procedure, surgical duration and age. Results: The most relevant contributor to medical costs was operating room occupation (46%), followed by hospital stay (30%) and medical devices (15%). Patients in the HPI group had EURO 300 greater outlay for medical devices without major differences in total costs (GDT 5425 (3505, 8127), HPI 5227 (4201, 7023) p = 0.697). A pre-specified subgroup analysis of 50% of patients undergoing laparotomic surgery showed similar medical device costs and total costs, with a non-significant saving of EUR 1000 in the HPI group (GDT 8005 (5961, 9679), HPI 7023 (5227, 11,438), p = 0.945). The hospital LOS and intensive care unit stay were similar in the cohorts and subgroups. Conclusions: Implementation of HPI is associated with a scenario of cost neutrality, with possible economic advantage in high-risk settings.
- 30 December 2023
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 14 (1) , 58
Open AccessPersonalized Predictive Hemodynamic Management for Gynecologic Oncologic Surgery: Feasibility of Cost–Benefit Derivatives of Digital Medical Devices
Background: Intraoperative hypotension is associated with increased perioperative complications, hospital length of stay (LOS) and healthcare expenditure in gynecologic surgery. We tested the hypothesis that the adoption of a machine learning-based warning algorithm (hypotension prediction index—HPI) might yield an economic advantage, with a reduction in adverse outcomes that outweighs the costs for its implementation as a medical device. Methods: A retrospective-matched cohort cost–benefit Italian study in gynecologic surgery was conducted. Sixty-six female patients treated with standard goal-directed therapy (GDT) were matched in a 2:1 ratio with thirty-three patients treated with HPI based on ASA status, diagnosis, procedure, surgical duration and age. Results: The most relevant contributor to medical costs was operating room occupation (46%), followed by hospital stay (30%) and medical devices (15%). Patients in the HPI group had EURO 300 greater outlay for medical devices without major differences in total costs (GDT 5425 (3505, 8127), HPI 5227 (4201, 7023) p = 0.697). A pre-specified subgroup analysis of 50% of patients undergoing laparotomic surgery showed similar medical device costs and total costs, with a non-significant saving of EUR 1000 in the HPI group (GDT 8005 (5961, 9679), HPI 7023 (5227, 11,438), p = 0.945). The hospital LOS and intensive care unit stay were similar in the cohorts and subgroups. Conclusions: Implementation of HPI is associated with a scenario of cost neutrality, with possible economic advantage in high-risk settings.
- Open Access
- 19 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (14) , 4775
Blended (Combined Spinal and General) vs. General Anesthesia for Abdominal Hysterectomy: A Retrospective Study
Background: Adequate pain management for abdominal hysterectomy is a key factor to decrease postoperative morbidity, hospital length of stay and chronic pain. General anesthesia is still the most widely used technique for abdominal hysterectomy. The aim of this study was to assess the efficacy and safety of blended anesthesia (spinal and general anesthesia) compared to balanced general anesthesia in patients undergoing hysterectomy with or without lymphadenectomy for ovarian, endometrial or cervical cancer or for fibromatosis. Methods: We retrospectively collected data from adult ASA 1 to 3 patients scheduled for laparoscopic or mini-laparotomic hysterectomy with or without lymphadenectomy for ovarian, endometrial or cervical cancer or for fibromatosis. Exclusion criteria were age below 18 years, ASA > 3, previous chronic use of analgesics, psychiatric disorders, laparotomic surgery with an incision above the belly button and surgery extended to the upper abdomen for the presence of cancer localizations (e.g., liver, spleen or diaphragm surgery). The cohort of patients was retrospectively divided into three groups according to the anesthetic management: general anesthesia and spinal with morphine and local anesthetic (Group 1), general anesthesia and spinal with morphine (Group 2) and general anesthesia without spinal (Group 3). Results: NRS was lower in the spinal anesthesia groups (Groups 1 and 2) than in the general anesthesia group (Group 3) for every time point but at 48 h. The addition of local anesthetics conferred a small but significant NRS decrease (p = 0.009). A higher percentage of patients in Group 3 received intraoperative sufentanil (52.2 ± 18 mcg in Group 3 vs. Group 1 31.8 ± 16.2 mcg, Group 2 44.1 ± 15.6, p < 0.001) and additional techniques for postoperative pain control (11.4% in Group 3 vs. 2.1% in Group 1 and 0.8% in Group 2, p < 0.001). Intraoperative hypotension (MAP < 65 mmHg) lasting more than 5 min was more frequent in patients receiving spinal anesthesia, especially with local anesthetics (Group 1 25.8%, Group 2 14.6%, Group 3 11.6%, p < 0.001), with the resulting increased need for vasopressors. Recovery-room discharge criteria were met earlier in the spinal anesthesia groups than in the general anesthesia group (Group 1 102 ± 44 min, Group 2 91.9 ± 46.5 min, Group 3 126 ± 90.7 min, p < 0.05). No differences were noted in postoperative mobilization or duration of ileus. Conclusions: Intrathecal administration of morphine with or without local anesthetic as a component of blended anesthesia is effective in improving postoperative pain control following laparoscopic or mini-laparotomic hysterectomy, in reducing intraoperative opioid consumption, in decreasing postoperative rescue analgesics consumption and the need for any additional analgesic technique. We recommend managing postoperative pain with a strategy tailored to the patient’s physical status and the type of surgery, preventing and treating side effects of pain treatments.
- 19 July 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (14) , 4775
Open AccessBlended (Combined Spinal and General) vs. General Anesthesia for Abdominal Hysterectomy: A Retrospective Study
Background: Adequate pain management for abdominal hysterectomy is a key factor to decrease postoperative morbidity, hospital length of stay and chronic pain. General anesthesia is still the most widely used technique for abdominal hysterectomy. The aim of this study was to assess the efficacy and safety of blended anesthesia (spinal and general anesthesia) compared to balanced general anesthesia in patients undergoing hysterectomy with or without lymphadenectomy for ovarian, endometrial or cervical cancer or for fibromatosis. Methods: We retrospectively collected data from adult ASA 1 to 3 patients scheduled for laparoscopic or mini-laparotomic hysterectomy with or without lymphadenectomy for ovarian, endometrial or cervical cancer or for fibromatosis. Exclusion criteria were age below 18 years, ASA > 3, previous chronic use of analgesics, psychiatric disorders, laparotomic surgery with an incision above the belly button and surgery extended to the upper abdomen for the presence of cancer localizations (e.g., liver, spleen or diaphragm surgery). The cohort of patients was retrospectively divided into three groups according to the anesthetic management: general anesthesia and spinal with morphine and local anesthetic (Group 1), general anesthesia and spinal with morphine (Group 2) and general anesthesia without spinal (Group 3). Results: NRS was lower in the spinal anesthesia groups (Groups 1 and 2) than in the general anesthesia group (Group 3) for every time point but at 48 h. The addition of local anesthetics conferred a small but significant NRS decrease (p = 0.009). A higher percentage of patients in Group 3 received intraoperative sufentanil (52.2 ± 18 mcg in Group 3 vs. Group 1 31.8 ± 16.2 mcg, Group 2 44.1 ± 15.6, p < 0.001) and additional techniques for postoperative pain control (11.4% in Group 3 vs. 2.1% in Group 1 and 0.8% in Group 2, p < 0.001). Intraoperative hypotension (MAP < 65 mmHg) lasting more than 5 min was more frequent in patients receiving spinal anesthesia, especially with local anesthetics (Group 1 25.8%, Group 2 14.6%, Group 3 11.6%, p < 0.001), with the resulting increased need for vasopressors. Recovery-room discharge criteria were met earlier in the spinal anesthesia groups than in the general anesthesia group (Group 1 102 ± 44 min, Group 2 91.9 ± 46.5 min, Group 3 126 ± 90.7 min, p < 0.05). No differences were noted in postoperative mobilization or duration of ileus. Conclusions: Intrathecal administration of morphine with or without local anesthetic as a component of blended anesthesia is effective in improving postoperative pain control following laparoscopic or mini-laparotomic hysterectomy, in reducing intraoperative opioid consumption, in decreasing postoperative rescue analgesics consumption and the need for any additional analgesic technique. We recommend managing postoperative pain with a strategy tailored to the patient’s physical status and the type of surgery, preventing and treating side effects of pain treatments.
- Open Access
- 6 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (12) , 3869
Real Evidence and Misconceptions about Malignant Hyperthermia in Children: A Narrative Review
Malignant hyperthermia is a rare but life-threatening pharmacogenetic disorder triggered by exposure to specific anesthetic agents. Although this occurrence could affect virtually any patient during the perioperative time, the pediatric population is particularly vulnerable, and it has a five-fold higher incidence in children compared to adults. In the last few decades, synergistic efforts among leading anesthesiology, pediatrics, and neurology associations have produced new evidence concerning the diagnostic pathway, avoiding unnecessary testing and limiting false diagnoses. However, a personalized approach and an effective prevention policy focused on clearly recognizing the high-risk population, defining perioperative trigger-free hospitalization, and rapid activation of supportive therapy should be improved. Based on epidemiological data, many national scientific societies have produced consistent guidelines, but many misconceptions are common among physicians and healthcare workers. This review shall consider all these aspects and summarize the most recent updates.
- 6 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (12) , 3869
Open AccessReal Evidence and Misconceptions about Malignant Hyperthermia in Children: A Narrative Review
Malignant hyperthermia is a rare but life-threatening pharmacogenetic disorder triggered by exposure to specific anesthetic agents. Although this occurrence could affect virtually any patient during the perioperative time, the pediatric population is particularly vulnerable, and it has a five-fold higher incidence in children compared to adults. In the last few decades, synergistic efforts among leading anesthesiology, pediatrics, and neurology associations have produced new evidence concerning the diagnostic pathway, avoiding unnecessary testing and limiting false diagnoses. However, a personalized approach and an effective prevention policy focused on clearly recognizing the high-risk population, defining perioperative trigger-free hospitalization, and rapid activation of supportive therapy should be improved. Based on epidemiological data, many national scientific societies have produced consistent guidelines, but many misconceptions are common among physicians and healthcare workers. This review shall consider all these aspects and summarize the most recent updates.
- Open Access
- 18 October 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (20) , 6124
The Effect of Epidural Analgesia on Labour and Neonatal and Maternal Outcomes in 1, 2a, 3, and 4a Robson’s Classes: A Propensity Score-Matched Analysis
Background: Lumbar epidural analgesia (EA) is the most commonly used method for reducing labour pain, but its impact on the duration of the second stage of labour and on neonatal and maternal outcomes remains a matter of debate. Our aim was to examine whether EA affected the course and the outcomes of labour among patients divided according to the Robson-10 group classification system. Methods: Patients of Robson’s classes 1, 2a, 3, and 4a were divided into either the EA group or the non-epidural analgesia (NEA) group. A propensity score-matching analysis was performed to balance the intergroup differences. The primary goal was to analyse the duration of the second stage of labour. The secondary goals were to evaluate neonatal and maternal outcomes. Results: In total, 21,808 cases were analysed. The second stage of labour for all groups was prolonged using EA (p < 0.05) without statistically significant differences in neonatal outcomes. EA resulted in a lower rate of episiotomies in nulliparous patients, with a higher rate of operative vaginal deliveries (OVD) (p < 0.05) and Caesarean sections (CS) (p < 0.05) in some classes. Conclusions: EA prolonged the duration of labour without affecting neonatal outcomes and reduced the rate of episiotomies, but also increased the rate of OVDs.
- 18 October 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (20) , 6124
Open AccessThe Effect of Epidural Analgesia on Labour and Neonatal and Maternal Outcomes in 1, 2a, 3, and 4a Robson’s Classes: A Propensity Score-Matched Analysis
Background: Lumbar epidural analgesia (EA) is the most commonly used method for reducing labour pain, but its impact on the duration of the second stage of labour and on neonatal and maternal outcomes remains a matter of debate. Our aim was to examine whether EA affected the course and the outcomes of labour among patients divided according to the Robson-10 group classification system. Methods: Patients of Robson’s classes 1, 2a, 3, and 4a were divided into either the EA group or the non-epidural analgesia (NEA) group. A propensity score-matching analysis was performed to balance the intergroup differences. The primary goal was to analyse the duration of the second stage of labour. The secondary goals were to evaluate neonatal and maternal outcomes. Results: In total, 21,808 cases were analysed. The second stage of labour for all groups was prolonged using EA (p < 0.05) without statistically significant differences in neonatal outcomes. EA resulted in a lower rate of episiotomies in nulliparous patients, with a higher rate of operative vaginal deliveries (OVD) (p < 0.05) and Caesarean sections (CS) (p < 0.05) in some classes. Conclusions: EA prolonged the duration of labour without affecting neonatal outcomes and reduced the rate of episiotomies, but also increased the rate of OVDs.
- 13 May 2020
- Published by Wolters Kluwer Health in Shock
- Vol. 54 (5) , 675-680
Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients
Objective: To investigate the behavior of pentraxin-3 (PTX3), troponin T (hsTnT), N-terminal pro-B type Natriuretic Peptide (NT-proBNP) in sepsis and their relationships with sepsis severity and oxygen transport/utilization impairment. Design: Retrospective analysis of PTX3, hsTnT, NT-proBNP levels at day 1, 2, and 7 after admission in the intensive care unit in a subset of the Albumin Italian Outcome Sepsis database. Setting: Forty Italian intensive care units. Patients: Nine hundred fifty-eight septic patients enrolled in the randomized clinical trial comparing albumin replacement plus crystalloids and crystalloids alone. Interventions: The patients were divided into sextiles of lactate (marker of severity), ScvO2 (marker of oxygen transport), and fluid balance (marker of therapeutic strategy). Measurements and Main Results: PTX3 and hsTnT were remarkably similar in the two treatment arms, while NT-proBNP was almost double in the albumin treatment group. However, as the distribution of all these biomarkers was similar between control and treatment arms, for the sake of clarity, we analyzed the patients as a single cohort. PTX3 (71.8 [32.9–186.3] ng/mL), hsTnT (50.4 [21.6–133.6] ng/L), and NT-proBNP (4,393 [1,313–13,837] ng/L) were abnormally elevated in 100%, 84.5%, 93.4% of the 953 patients and all decreased from day 1 to day 7. PTX3 monotonically increased with increasing lactate levels. The hsTnT levels were significantly higher when ScvO2 levels were abnormally low (< 70%), suggesting impaired oxygen transport compared with higher ScvO2 levels, suggesting impaired oxygen utilization. NT-proBNP was higher with higher lactate and fluid balance. At ScvO2 levels < 70%, the NT-proBNP was higher than at higher ScvO2 levels. However, even with higher ScvO2, the NT-proBNP was remarkably elevated, suggesting volume expansion. Increased level of NT-proBNP showed the strongest association with 90-day mortality. Conclusions: The selected biomarkers seem related to different mechanisms during sepsis: PTX3 to sepsis severity, hsTnT to impaired oxygen transport, NT-proBNP to sepsis severity, oxygen transport, and aggressive fluid strategy.
- 13 May 2020
- Published by Wolters Kluwer Health in Shock
- Vol. 54 (5) , 675-680
Pentraxin-3, Troponin T, N-Terminal Pro-B-Type Natriuretic Peptide in Septic Patients
Objective: To investigate the behavior of pentraxin-3 (PTX3), troponin T (hsTnT), N-terminal pro-B type Natriuretic Peptide (NT-proBNP) in sepsis and their relationships with sepsis severity and oxygen transport/utilization impairment. Design: Retrospective analysis of PTX3, hsTnT, NT-proBNP levels at day 1, 2, and 7 after admission in the intensive care unit in a subset of the Albumin Italian Outcome Sepsis database. Setting: Forty Italian intensive care units. Patients: Nine hundred fifty-eight septic patients enrolled in the randomized clinical trial comparing albumin replacement plus crystalloids and crystalloids alone. Interventions: The patients were divided into sextiles of lactate (marker of severity), ScvO2 (marker of oxygen transport), and fluid balance (marker of therapeutic strategy). Measurements and Main Results: PTX3 and hsTnT were remarkably similar in the two treatment arms, while NT-proBNP was almost double in the albumin treatment group. However, as the distribution of all these biomarkers was similar between control and treatment arms, for the sake of clarity, we analyzed the patients as a single cohort. PTX3 (71.8 [32.9–186.3] ng/mL), hsTnT (50.4 [21.6–133.6] ng/L), and NT-proBNP (4,393 [1,313–13,837] ng/L) were abnormally elevated in 100%, 84.5%, 93.4% of the 953 patients and all decreased from day 1 to day 7. PTX3 monotonically increased with increasing lactate levels. The hsTnT levels were significantly higher when ScvO2 levels were abnormally low (< 70%), suggesting impaired oxygen transport compared with higher ScvO2 levels, suggesting impaired oxygen utilization. NT-proBNP was higher with higher lactate and fluid balance. At ScvO2 levels < 70%, the NT-proBNP was higher than at higher ScvO2 levels. However, even with higher ScvO2, the NT-proBNP was remarkably elevated, suggesting volume expansion. Increased level of NT-proBNP showed the strongest association with 90-day mortality. Conclusions: The selected biomarkers seem related to different mechanisms during sepsis: PTX3 to sepsis severity, hsTnT to impaired oxygen transport, NT-proBNP to sepsis severity, oxygen transport, and aggressive fluid strategy.